252
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia

ORCID Icon, & ORCID Icon
Pages 425-433 | Published online: 16 Apr 2021

References

  • Unaids J Fact sheet—latest global and regional statistics on the status of the AIDS epidemic. Geneva: UNAIDS; 2017.
  • HIV/AIDS JUNPo. UNAIDS report on the global AIDS epidemic 2013. Geneva: UNAIDS; 2013: 201.
  • UNAIDS. Global AIDS update; 2016:16.
  • Kibret GD, Ferede A, Leshargie CT, Wagnew F, Ketema DB, Alebel A. Trends and spatial distributions of HIV prevalence in Ethiopia. Infect Dis Poverty. 2019;8(1):90. doi:10.1186/s40249-019-0594-9
  • Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013;13(11):976–986. doi:10.1016/S1473-3099(13)70269-X
  • Antinori A, Arendt G, Becker J, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–1799. doi:10.1212/01.WNL.0000287431.88658.8b
  • Sadock BJ, Sadock VA. Kaplan and Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. lippincott williams & wilkins; 2011.
  • Belete T, Medfu G, Yemiyamrew E. Prevalence of HIV associated neurocognitive deficit among HIV positive people in Ethiopia: a cross sectional study at Ayder Referral Hospital. Ethiop J Health Sci. 2017;27(1):67–76. doi:10.4314/ejhs.v27i1.9
  • Chan LG, Kandiah N, Chua A. HIV-associated neurocognitive disorders (HAND) in a South Asian population-contextual application of the 2007 criteria. BMJ Open. 2012;2(1):e000662. doi:10.1136/bmjopen-2011-000662
  • Mohamed AA, Oduor C, Kinyanjui D. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya. BMC Neurol. 2020;20(1):1–11. doi:10.1186/s12883-020-01857-3
  • Kelly CM, van Oosterhout JJ, Ngwalo C, et al. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. PLoS One. 2014;9(6):e98962. doi:10.1371/journal.pone.0098962
  • Achappa B, Priyadarshni S, Madi D, et al. Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale. Asian J Med Sci. 2014;5(4):61–64. doi:10.3126/ajms.v5i4.8724
  • Focà E, Magro P, Motta D, et al. Screening for neurocognitive impairment in HIV-infected individuals at first contact after HIV diagnosis: the experience of a large clinical center in Northern Italy. Int J Mol Sci. 2016;17(4):434. doi:10.3390/ijms17040434
  • Heaton R, Clifford D, Franklin D, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23):2087–2096. doi:10.1212/WNL.0b013e318200d727
  • Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ–4. Psychosomatics. 2009;50(6):613–621. doi:10.1176/appi.psy.50.6.613
  • Dalgard OS, Dowrick C, Lehtinen V, et al. Negative life events, social support and gender difference in depression. Soc Psychiatry Psychiatr Epidemiol. 2006;41(6):444–451. doi:10.1007/s00127-006-0051-5
  • Dalgard O. Community health profile as tool for psychiatric prevention. Promot Ment Health. 1996;5:681–695.
  • Martikainen P, Aromaa A, Heliövaara M, et al. Reliability of perceived health by sex and age. Soc Sci Med. 1999;48(8):1117–1122. doi:10.1016/S0277-9536(98)00416-X
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-6
  • Salahuddin M, Manzar MD, Hassen HY, et al. Prevalence and predictors of neurocognitive impairment in ethiopian population living with HIV. HIV AIDS (Auckl). 2020;12:559.
  • Tsegaw M, Andargie G, Alem G, Tareke M. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia. J Psychiatr Res. 2017;85:37–41. doi:10.1016/j.jpsychires.2016.10.016
  • Lawler K, Mosepele M, Ratcliffe S, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc. 2010;13(1):15. doi:10.1186/1758-2652-13-15
  • Habib AG, Yakasai AM, Owolabi LF, et al. Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis. 2013;17(10):e820–e31. doi:10.1016/j.ijid.2013.06.011
  • Debalkie Animut M, Sorrie MB, Birhanu YW, Teshale MY. High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: a cross-sectional study. PLoS One. 2019;14(3):e0204636. doi:10.1371/journal.pone.0204636
  • Mossie TB, Tegegne MT. HIV dementia among HIV positive people at Debre markos hospital, Northwest Ethiopia. Am J Psychol Neurosci. 2014;2(2):18–24. doi:10.11648/j.ajpn.20140202.11